"safetyinformation" - 1 õppematerjal

NANDA õendusdiagnoosid 2012-2014 e-raamat

R.,ȱ Metzger,ȱ R.,ȱ Bonatti,ȱ H.,ȱ Sawyer,ȱ R.G.,ȱ &ȱ May,ȱ A.K.ȱ (2009).ȱObesityȱandȱsiteȬspecificȱnosocomialȱinfectionȱriskȱinȱtheȱintensiveȱcareȱunit.ȱSurgicalȱInfecȬ tions,ȱ10,ȱ137–142.ȱ Falagas,ȱM.E.,ȱ&ȱKompoti,ȱM.ȱ(2006).ȱObesityȱandȱInfection.ȱLancetȱInfectiousȱDiseases,ȱ6,ȱ438–446.ȱ Foodȱ andȱ Drugȱ Administrationȱ (2001).ȱ Importantȱ drugȱ warningȱ (Remicade).ȱ Retrievedȱ fromȱ http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm172751.htmȱ.ȱ FoodȱandȱDrugȱAdministrationȱ(2006).ȱFDAȱapprovesȱresumedȱmarketingȱofȱTysabriȱunderȱaȱspecialȱ distributionȱprogram.ȱRetrievedȱfromȱ http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncement/2006/ucm108662.htmȱ.ȱ FreeȱDictionaryȱ(2009).ȱInfection.ȱRetrievedȱfromȱhttp://medicalȬ dictionary.thefreedictionary.com/infection.ȱ GeaȬBanacloche,ȱJ.C.,ȱ&ȱWeinberg,ȱG.A.ȱ(2007)